272 related articles for article (PubMed ID: 32376798)
21. MicroRNA in Sjögren's Syndrome: Their Potential Roles in Pathogenesis and Diagnosis.
Reale M; D'Angelo C; Costantini E; Laus M; Moretti A; Croce A
J Immunol Res; 2018; 2018():7510174. PubMed ID: 29977932
[TBL] [Abstract][Full Text] [Related]
22. Increased interleukin (IL)-7Rα expression in salivary glands of patients with primary Sjogren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity.
Bikker A; Kruize AA; Wenting M; Versnel MA; Bijlsma JW; Lafeber FP; van Roon JA
Ann Rheum Dis; 2012 Jun; 71(6):1027-33. PubMed ID: 22312161
[TBL] [Abstract][Full Text] [Related]
23. Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome.
Soyfoo MS; Chivasso C; Perret J; Delporte C
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380700
[TBL] [Abstract][Full Text] [Related]
24. The T cell in Sjogren's syndrome: force majeure, not spectateur.
Singh N; Cohen PL
J Autoimmun; 2012 Sep; 39(3):229-33. PubMed ID: 22709856
[TBL] [Abstract][Full Text] [Related]
25. Innate immune signaling induces interleukin-7 production from salivary gland cells and accelerates the development of primary Sjögren's syndrome in a mouse model.
Jin JO; Shinohara Y; Yu Q
PLoS One; 2013; 8(10):e77605. PubMed ID: 24147035
[TBL] [Abstract][Full Text] [Related]
26. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
27. Restoration of CFTR Activity in Ducts Rescues Acinar Cell Function and Reduces Inflammation in Pancreatic and Salivary Glands of Mice.
Zeng M; Szymczak M; Ahuja M; Zheng C; Yin H; Swaim W; Chiorini JA; Bridges RJ; Muallem S
Gastroenterology; 2017 Oct; 153(4):1148-1159. PubMed ID: 28634110
[TBL] [Abstract][Full Text] [Related]
28. Cellular microRNAs (miRNAs) and Sjögren's syndrome: candidate regulators of autoimmune response and autoantigen expression.
Kapsogeorgou EK; Gourzi VC; Manoussakis MN; Moutsopoulos HM; Tzioufas AG
J Autoimmun; 2011 Sep; 37(2):129-35. PubMed ID: 21632209
[TBL] [Abstract][Full Text] [Related]
29. FcRL4
Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
[TBL] [Abstract][Full Text] [Related]
30. CD40 on salivary gland epithelial cells: high constitutive expression by cultured cells from Sjögren's syndrome patients indicating their intrinsic activation.
Dimitriou ID; Kapsogeorgou EK; Moutsopoulos HM; Manoussakis MN
Clin Exp Immunol; 2002 Feb; 127(2):386-92. PubMed ID: 11876766
[TBL] [Abstract][Full Text] [Related]
31. Modes and Mechanisms of Salivary Gland Epithelial Cell Death in Sjogren's Syndrome.
Zhou J; Pathak JL; Liu Q; Hu S; Cao T; Watanabe N; Huo Y; Li J
Adv Biol (Weinh); 2023 Dec; 7(12):e2300173. PubMed ID: 37409392
[TBL] [Abstract][Full Text] [Related]
32. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.
Fox RI; Kang HI; Ando D; Abrams J; Pisa E
J Immunol; 1994 Jun; 152(11):5532-9. PubMed ID: 8189070
[TBL] [Abstract][Full Text] [Related]
33. IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer.
Nguyen CQ; Yin H; Lee BH; Chiorini JA; Peck AB
Lab Invest; 2011 Jan; 91(1):54-62. PubMed ID: 20856230
[TBL] [Abstract][Full Text] [Related]
34. Zonula occludens-1, occludin and E-cadherin expression and organization in salivary glands with Sjögren's syndrome.
Mellas RE; Leigh NJ; Nelson JW; McCall AD; Baker OJ
J Histochem Cytochem; 2015 Jan; 63(1):45-56. PubMed ID: 25248927
[TBL] [Abstract][Full Text] [Related]
35. Pro-inflammatory cytokines enhance ERAD and ATF6α pathway activity in salivary glands of Sjögren's syndrome patients.
Barrera MJ; Aguilera S; Castro I; Cortés J; Bahamondes V; Quest AFG; Molina C; González S; Hermoso M; Urzúa U; Leyton C; González MJ
J Autoimmun; 2016 Dec; 75():68-81. PubMed ID: 27461470
[TBL] [Abstract][Full Text] [Related]
36. Autoantigen-targeting microRNAs in Sjögren's syndrome.
Yang Y; Peng L; Ma W; Yi F; Zhang Z; Chen H; Guo Y; Wang L; Zhao LD; Zheng W; Li J; Zhang F; Du Q
Clin Rheumatol; 2016 Apr; 35(4):911-7. PubMed ID: 26888739
[TBL] [Abstract][Full Text] [Related]
37. Decreased expression of thymic stromal lymphopoietin in salivary glands of patients with primary Sjögren's syndrome is associated with increased disease activity.
Hillen MR; Kruize AA; Bikker A; Wenting-van Wijk M; Radstake TR; Hack CE; Lafeber FP; van Roon JA
Mod Rheumatol; 2016; 26(1):105-9. PubMed ID: 25995032
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-21-mediated suppression of the Pax3-Id3 pathway exacerbates the development of Sjögren's syndrome via follicular helper T cells.
Park JS; Kim SM; Choi J; Jung KA; Hwang SH; Yang S; Kwok SK; Cho ML; Park SH
Cytokine; 2020 Jan; 125():154834. PubMed ID: 31491724
[TBL] [Abstract][Full Text] [Related]
39. Proteomic and histopathological characterisation of sicca subjects and primary Sjögren's syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers.
Aqrawi LA; Galtung HK; Guerreiro EM; Øvstebø R; Thiede B; Utheim TP; Chen X; Utheim ØA; Palm Ø; Skarstein K; Jensen JL
Arthritis Res Ther; 2019 Jul; 21(1):181. PubMed ID: 31366407
[TBL] [Abstract][Full Text] [Related]
40. CCL22-Producing Resident Macrophages Enhance T Cell Response in Sjögren's Syndrome.
Ushio A; Arakaki R; Otsuka K; Yamada A; Tsunematsu T; Kudo Y; Aota K; Azuma M; Ishimaru N
Front Immunol; 2018; 9():2594. PubMed ID: 30467506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
